Action Alerts PLUS
RealMoney Silver
Stocks Under $10
Options Alerts
Top Stocks
View All


Now, enjoy the good life every day!

RSSRSS FEEDS
PODPODCASTS



RealMoney.com: Investing
Print This Story

Activist Track: Chapman Takes On Texas

By James Altucher
RealMoney.com Contributor

6/9/2006 1:59 PM EDT
Click here for more stories by James Altucher
 
 Carreker (CANI:Nasdaq) BULLISH
Price: $6.58  |  52-Week Range: $4.24-$7.65
  • Chapman Capital targets a small-cap name in its return to activism.
  • The letter excoriates the company's management and its piggyback shareholders.
  • The firm's research shows its target at a significant premium to the current price.
Position: none

The most anticipated 13D filing of the summer broke last night, and a brief excerpt of this filing may clue you in to the activist:



To be honest, I begin to retch at the image of my flying into Dallas to attend a board meeting as a minority director, outweighed by the group-think-driven crew listed in the addressee section above. I have nightmares involving my choking down gourmet tuna sandwiches and uninformed, "long term" business judgments, both being served in abundant quantity by you and your Texas "pardners."

Yep you guessed it; Robert Chapman of Chapman Capital is at it again. Chapman restarted his fund after a two-year hiatus since breaking his back in a surfing accident and then traveling the world after his recovery. Previously, his 13D filings were anxiously read by investors and feared by CEOs. Bob once told me, "Before I would file a 13D filing, I would call a CEO and let him know, 'Your life is about to change.'" Nobody wants to be on the other side of that call, because their lives are not going to change for the better.

His target is Carreker Corporation (CANI - commentary - Cramer's Take), a small-cap company that provides payment-related software and consulting solutions to financial institutions and financial service providers worldwide. According to Chapman's filing, he owns 5.6% of the 25.33 million shares outstanding, at an average price of $5.53. But, as ever with Chapman activism battles, it's best to let him do the talking.

Chapman begins the filing by stating: "To put our ownership into perspective, our hedge funds' financial interest in Carreker's common equity now exceeds non-family/Prescott directors' ownership by a factor of nearly 5-to-1. Interestingly, Carreker's insiders seem to have enjoyed extraordinary wealth by selling shares to new, potentially less-informed public shareholders."

Family-run companies always make for an interesting activist case, especially when there is nepotism and weak family ownership.

Chapman then says: "Chapman Capital believes that Carreker's long-time (i.e., excluding recently appointed) Board of Directors has been decidedly derelict in its duty to maximize the long-term value of the Company. Nearly one year ago on July 6, 2005, Prescott Group Capital Management, L.L.C. (hereinafter, 'Prescott'), then and now a 7.2% owner of Carreker 14 having paid approximately the market price at that time 15 of $5.70 per share 16, publicly noted that 'several direct competitors to the Issuer have recently been sold at significantly higher valuation metrics than the Issuer current enjoys. Following this latest year-long episode of a five-year horror show produced by you and the pre-Watkins Board, we hereby petition that Carreker immediately retain an investment bank to evaluate and subsequently consummate the most attractive of a variety of strategic alternatives.'"

Go to NEXT PAGE


 RELATED STORIES

Investing
Activist Track: Topps Won't Flip for Activists
6/7/2006 11:20 AM EDT
Two funds find that capital allocation is at fault, but the company takes issue with the assault.

Investing
Activist Track: Some Portfolio Ketchup
5/24/2006 10:22 AM EDT
The elaborate and dogged activist fight of Trian should bolster Heinz stock.

Hedge Funds
Hedge Fund Report: Icahn Alum Targets Atmel
5/23/2006 2:57 PM EDT
Russell Glass is unlikely to take 'no' for an answer. Plus, less sell-side research is good for hedge funds.

Hedge Funds
Hedge Fund Report: Activists Don't Always Shout
5/22/2006 11:41 AM EDT
Even Dan Loeb is staying mum about Zoltek. Plus, regulation takes a step back.



James Altucher is a managing partner at Formula Capital, an alternative asset management firm that runs several quantitative-based hedge funds as well as a fund of hedge funds. He is also the author of Trade Like a Hedge Fund and Trade Like Warren Buffett. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Altucher appreciates your feedback; click here to send him an email.

Interested in more writings from James Altucher? Check out his newsletter, TheStreet.com Internet Review. For more information, click here.

TheStreet.com has a revenue-sharing relationship with Trader's Library under which it receives a portion of the revenue from purchases by customers directed there from TheStreet.com.

Write us!
Order reprints of TSC articles. Top




Partner Center


Advertisement


Investor Relations | Privacy Policy | Terms of Use | Conflicts Policy | Corrections | Internet Index | Advertise | FAQ
Site Map | Who's Who | Reader Feedback | Employment | Contact Us
RSSSubscribe to our RSS Feed
© 1996- TheStreet.com, Inc. All rights reserved.
TheStreet.com's enterprise databases running Oracle are professionally monitored and managed by Pythian Remote DBA.